id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0007-0055,FDA,FDA-2006-P-0007,Tab 3 re Supplement from ViroPharma Incorporated,Supporting & Related Material,Background Material,2014-01-31T05:00:00Z,2014,1,,,2014-02-01T00:32:45Z,,0,0,0900006480441478
FDA-2006-P-0007-0053,FDA,FDA-2006-P-0007,Supplement from ViroPharma Incorporated,Other,Supplement (SUP),2014-01-31T05:00:00Z,2014,1,2014-01-31T05:00:00Z,,2014-01-31T23:37:55Z,,0,0,0900006480924c45
FDA-2006-P-0007-0062,FDA,FDA-2006-P-0007,Comment from D. Robertson re Conference Call Transcript,Supporting & Related Material,Background Material,2014-01-31T05:00:00Z,2014,1,,,2014-02-01T00:52:43Z,,0,0,0900006480441492
FDA-2006-P-0007-0056,FDA,FDA-2006-P-0007,Comment from Diane Robertson,Supporting & Related Material,Electronic Comment (EC),2014-01-31T05:00:00Z,2014,1,,,2014-02-01T00:32:52Z,,0,0,0900006480441494
FDA-2006-P-0007-0052,FDA,FDA-2006-P-0007,"FDA/CDER Interim Response to ViroPharm, Inc.",Other,,2012-04-12T00:00:00Z,2012,4,,,2012-05-04T13:23:32Z,,0,1,0900006480fee22f
FDA-2006-P-0007-0051,FDA,FDA-2006-P-0007,Petition Partial Approval and Denial from FDA/CDER to ViroPharma Inc.,Other,Partial Petition Approval and Denial,2012-04-09T04:00:00Z,2012,4,2012-04-09T04:00:00Z,,2014-01-31T19:18:19Z,,0,0,0900006480fec3d7
FDA-2006-P-0007-0026,FDA,FDA-2006-P-0007,ViroPharma Incorporated (ViroPharma) - Supplement,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T18:06:45Z,,0,0,0900006480441477
FDA-2006-P-0007-0023,FDA,FDA-2006-P-0007,ViroPharma Incorporated - Supplement Petition,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T17:35:00Z,,0,0,090000648081061f
FDA-2006-P-0007-0028,FDA,FDA-2006-P-0007,ViroPharma Inc. - Supplement,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T20:26:13Z,,0,0,090000648044149b
FDA-2006-P-0007-0027,FDA,FDA-2006-P-0007,ViroPharma Incorporated (ViroPharma) - Supplement,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T18:12:03Z,,0,0,0900006480441479
FDA-2006-P-0007-0025,FDA,FDA-2006-P-0007,ViroPharma Incorporated (ViroPharma) - Supplement,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T18:00:35Z,,0,0,0900006480441476
FDA-2006-P-0007-0024,FDA,FDA-2006-P-0007,ViroPharma Incorporated (ViroPharma) - Supplement,Other,SUP-Supplement,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2009-01-06T17:45:41Z,,0,0,0900006480441475
FDA-2006-P-0007-0022,FDA,FDA-2006-P-0007,See Document ID FDA-2008-D-0626-0002 re Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl Notice of Availability  Reference,Supporting & Related Material,REF-Reference Material (external attachments),2008-12-24T05:00:00Z,2008,12,,,2014-02-01T00:56:34Z,,0,0,09000064807f2141
FDA-2006-P-0007-0019,FDA,FDA-2006-P-0007,FDA/ViroPharma - Minutes of Meeting,Other,MM-Memorandum of Meeting,2008-12-11T05:00:00Z,2008,12,2008-12-11T05:00:00Z,,2008-12-21T03:21:44Z,,0,0,09000064807d7b1e
FDA-2006-P-0007-0021,FDA,FDA-2006-P-0007,ViroPharma Slide Presentation Vancocin Bioequivalence (BE) Appropriate Method Development FDA Meeting January 7 2008  re FDA-2006-P-0007-0020,Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-11T05:00:00Z,2008,12,,,2014-02-01T00:54:04Z,,0,0,09000064807d7d80
FDA-2006-P-0007-0020,FDA,FDA-2006-P-0007,ViroPharma Incorporated - Letter,Other,LET-Letter,2008-12-11T05:00:00Z,2008,12,2008-12-11T05:00:00Z,,2010-11-03T16:48:34Z,,0,0,09000064807d7d09
FDA-2006-P-0007-0018,FDA,FDA-2006-P-0007,ViroPharma Incorporated - Supplement Petition,Other,SUP-Supplement,2008-12-11T05:00:00Z,2008,12,2008-12-11T05:00:00Z,,2013-07-27T22:19:34Z,,0,0,090000648069607b
FDA-2006-P-0007-0016,FDA,FDA-2006-P-0007,ViroPharma - Supplement,Other,SUP-Supplement,2008-06-23T04:00:00Z,2008,6,2008-06-23T04:00:00Z,,2008-06-24T00:30:39Z,,0,0,090000648062bae0
FDA-2006-P-0007-0014,FDA,FDA-2006-P-0007,"Congressional Record - Senate (S5649-5650), May 7, 2007 - [D. Robertson - Comment]",Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-04-16T04:00:00Z,2008,4,,,2009-02-10T17:36:41Z,,0,0,0900006480441490
FDA-2006-P-0007-0006,FDA,FDA-2006-P-0007,ViroPharm Incorporated - Letter,Other,LET-Letter,2008-04-16T04:00:00Z,2008,4,2008-04-16T04:00:00Z,,2008-04-16T23:22:23Z,,0,0,0900006480441455
FDA-2006-P-0007-0003,FDA,FDA-2006-P-0007,Petition for stay from ViroPharma Incorporated,Other,PSA-Petition for Stay,2008-04-16T04:00:00Z,2008,4,2008-04-16T04:00:00Z,,2019-07-08T14:48:05Z,,0,0,0900006480441450
FDA-2006-P-0007-0007,FDA,FDA-2006-P-0007,"ViroPharma, Inc. - SUP  - Supplement",Other,SUP-Supplement,2008-04-16T04:00:00Z,2008,4,2008-04-16T04:00:00Z,,2019-07-08T14:48:59Z,,0,0,090000648044146d
FDA-2006-P-0007-0015,FDA,FDA-2006-P-0007,See FDA-2006-P-0007-0014,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-04-16T04:00:00Z,2008,4,,,2009-02-10T17:37:31Z,,0,0,0900006480441498
FDA-2006-P-0007-0004,FDA,FDA-2006-P-0007,"Petition for Stay from ViroPharma Incorporated March 30, 2006",Other,PSA-Petition for Stay,2008-04-16T04:00:00Z,2008,4,2008-04-16T04:00:00Z,,2019-07-08T14:48:34Z,,0,0,0900006480441452
FDA-2006-P-0007-0005,FDA,FDA-2006-P-0007,Acknowledgement Letter to ViroPharma Incorporated,Other,ACK-Acknowledgement Letter,2008-04-16T04:00:00Z,2008,4,2008-04-16T04:00:00Z,,2008-06-24T00:32:45Z,,0,0,0900006480441454
FDA-2006-P-0007-0001,FDA,FDA-2006-P-0007,Acknowledgement Letter to ViroPharma,Other,ACK-Acknowledgement Letter,2006-03-17T05:00:00Z,2006,3,,,2014-02-01T21:21:53Z,,0,0,090000648044144d
FDA-2006-P-0007-0002,FDA,FDA-2006-P-0007,Acknowledgement Letter to ViroPharma Incorporated,Other,ACK-Acknowledgement Letter,2006-03-17T05:00:00Z,2006,3,,,2014-02-01T01:12:13Z,,0,0,0900006480441451